Profound Medical Corp.
PROF · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $185,989 | $179,840 | $226,837 | $229,813 |
| - Cash | $54,912 | $26,213 | $46,517 | $67,061 |
| + Debt | $5,121 | $7,867 | $8,230 | $1,375 |
| Enterprise Value | $136,198 | $161,494 | $188,550 | $164,127 |
| Revenue | $10,167 | $7,199 | $6,681 | $6,873 |
| % Growth | 41.2% | 7.8% | -2.8% | – |
| Gross Profit | $6,699 | $4,382 | $3,021 | $2,952 |
| % Margin | 65.9% | 60.9% | 45.2% | 43% |
| EBITDA | -$25,591 | -$26,781 | -$26,604 | -$28,648 |
| % Margin | -251.7% | -372% | -398.2% | -416.8% |
| Net Income | -$26,480 | -$28,569 | -$28,669 | -$30,699 |
| % Margin | -260.4% | -396.8% | -429.1% | -446.7% |
| EPS Diluted | -1.07 | -1.35 | -1.38 | -1.5 |
| % Growth | 20.7% | 2.2% | 8% | – |
| Operating Cash Flow | -$23,453 | -$22,609 | -$25,800 | -$22,360 |
| Capital Expenditures | $0 | $0 | $0 | -$593 |
| Free Cash Flow | -$23,453 | -$22,609 | -$25,800 | -$22,953 |